GENERAL RELEASE AND SEVERANCE AGREEMENTSeverance Agreement • February 7th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This General Release and Severance Agreement (this “Agreement”), dated as of January 29, 2023, is made and entered into by and between Steve Chaussy (“Employee”) and BioSig Technologies, Inc. (the “Company”).
COMMON STOCK PURCHASE WARRANT BIOSIG TECHNOLOGIES, INC.Common Stock Purchase Warrant • February 7th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 24, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioSig Technologies, Inc., a Delaware corporation (the “Company”), up to 124,904 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between Laidlaw & Company (UK) Ltd. And the Company, dated as of October 11, 2022.
